(Q39396355)

English

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

scientific article

Statements

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial (English)
1 reference
0 references
0 references
Jason Chesney
1 reference
Anna C Pavlick
1 reference
Kenneth F Grossmann
1 reference
David F McDermott
1 reference
Gerald P Linette
1 reference
Nicolas Meyer
1 reference
Jeffrey K Giguere
1 reference
Sanjiv S Agarwala
1 reference
Montaser Shaheen
1 reference
Marc S Ernstoff
1 reference
David R Minor
1 reference
April K Salama
1 reference
Matthew H Taylor
1 reference
Patrick A Ott
1 reference
Christine Horak
1 reference
Paul Gagnier
1 reference
Joel Jiang
1 reference
Michael A Postow
1 reference
9 September 2016
1 reference
17
1 reference
1558-1568
1 reference
11
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit